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Bacground: Laparoendoscopic single-site surgery (LESS) has been developed in an attempt to further reduce the
morbidity and scarring associated with laparoscopic surgery. In patients in whom there are indications to perform a
laparoscopic renal biopsy, LESS surgery is a valid alternative to mini invasive surgery and is becoming more
common. We report our experience on 14 renal biopsy procedures performed in a retroperitoneal LESS.
Methods: LESS renal biopsy was performed in 14 patients 18 to 80 years old (mean age 58.3 years) during a
36 month period. All procedures were performed by a single operator. The patient was in a standard flank position.
The procedure was performed using a 2.5 cm, single incision via a retroperitoneal access at the Petit’s triangle. A
5 mm biopsy forceps was used to collect the specimen under direct vision, and haemostasis was obtained with an
Argon beam probe and the application of oxidized regenerated cellulose gauze.
Results: Biopsy was performed successfully in all cases. Mean operative time was 52.64 min, blood loss was
minimal, and the hospital stay ranged from 12 to 24 hours. None of the patients required narcotics or additional
analgesia in the postoperative period. No postoperative complications occurred.
Conclusions: The LESS technique is safe, reliable (100% success), easy to learn, and offers subjective cosmetic
benefits to the patient. Minimal hospitalization requirement following retroperitoneal LESS biopsy is an additional
timely advantage over laparoscopic renal biopsy. We think that with the right indications (marked obesity, failure of
previous percutaneous biopsy attempts, a solitary kidney and coagulopathy) LESS renal biopsy is a good alternative
to laparoscopy. Our next step will be a randomized prospective study of LESS compared with laparoscopy for renal
biopsy to support our findings.
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Histological evaluation of renal parenchyma is often
essential in cases of several renal diseases with unex-
plained azotemia, proteinuria, hematuria, or systemic
disease. Pathological diagnosis often provides useful in-
formation in determining the prognosis and guiding the
treatment. Ultrasound-guided renal biopsy represents an
essential step in the study of renal diseases [1].
The last few decades have transformed the renal biopsy
into a safe technique that plays a central role in the
nephrological diagnostic approach [2].* Correspondence: alessio_zordani@hotmail.it
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cases yield inadequate tissue for histopathology diagnosis.
Moreover, percutaneous kidney biopsy is not without risk.
Over complications occurring in up to 13% of the cases,
and 6 to 7% of complications were considered major, need-
ing for an intervention such as transfusion of blood product
or invasive procedure (radiographic or surgical) [3].
Difficulty in localized and inaccurate biopsies may be
taken when patients are extremely obese, uncooperative,
or have an ectopic kidney or abnormal body habitus [4].
Gimenez et al. describes the first retroperitoneal lap-
aroscopic renal biopsy technique in 32 patients who pre-
viously failed ultrasound-guided biopsy and in whom the
approach was contraindicated [5]. Relative indications
for the laparoscopic approach include marked obesitytd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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solitary kidney, a coagulopathy, Jehovah’s Witness faith, and
in pediatric patients [7]. Laparoscopic renal biopsy is pre-
ferred in which the retroperitoneal laparoscopic approach
is able to obtain sufficient renal tissue, with minimal bleed-
ing complications and a minimally invasive approach.
With advances in endoscopic instrumentation and the
development of laparoscopic techniques, the minimally
invasive renal biopsy is safety and preferable [8]. Retro-
peritoneal laparoendoscopic single-site surgery (LESS)
has been developed in an attempt to further reduce
the morbidity and scarring associated with laparoscopic
surgery. Early clinical series have demonstrated the feasi-
bility of a broad range of retroperitoneal LESS urologic
procedures [9]. We present our preliminary experience




Between January 2011 and December 2013, 14 patients
(11 male and 4 female) between 18 to 80 years old (mean
age 58.8 years) were referred to our division for retro-
peritoneal LESS for renal biopsy. All these patients had
absolute contraindications for a percutaneous renal biopsy.
All patients had abnormal proteinuria and or renal in-
sufficiency, defined by a serum creatinine of >1.4 mg/dL
(14 cases) and were referred for a LESS renal biopsy. All
patients had undergone a complete evaluation by a
nephrologist beforehand. Proteinuria ranged between 75
to 721 mg/dL; average serum creatinine was 2.15 mg/dL
(range: 0.98 to 4.98). Three patients had morbid obesity;
mean body mass index was 55 kg/m2 (range: 51.3 to 60.5).
Of the entire group, three patient were ASA (American
Society of Anesthesia) class 1, eight were ASA class 2, and
three were ASA class 3 (morbid obesity). The indications
for pursuing a laparoscopic approach are listed in Table 1.
Patients were fully informed about the risks, benefits,
alternatives, personnel and the novelty of Retroperitoneal
LESS Renal Biopsy. Before surgery, we ensured that
each patient had provided consent for this procedure.
They were informed that retroperitoneal access via
Petit’s Triangle would be secured as a matter of routine
in each case and that, at the surgeon’s discretion, the
procedure would be converted to standard laparoscopic
surgery on failure to progress. Each patient was informed
that such elective conversion to standard laparoscopy was
not a complication but rather surgical prudence because
of the novelty of this procedure. All data were collected
retrospectively in excel file without any patient identifying
information. The techniques used were all part of routine
care at Department of Urology University of Modena and
Reggio Emilia, and since each patient signed a general
consent to the processing of personal data, formal ethicalapproval from our institutional review board was not
necessary.
Operative technique
Our retroperitoneal access side was the lumbar or Petit’s
triangle (Figure 1a), formed by the intersection of the ex-
ternal oblique and latissimus dorsi muscles at the iliac
crest. With the patient in the standard flank position
and the operating table flexed, the space between the
12th rib and iliac crest was maximized. This maneuver
allowed the surgeon to identify Petit’s triangle [10].
In all cases retroperitoneal access was created with a
laparoscopic visual reusable trocar, Ternamian EndoTIP
10 mm (Karl Storz®, Tuttlingen, Germany), and a 10 mm
laparoscope was used for blunt dissection of the aereolar
retroperitoneal fat (Figure 1b). Afterwards, a 10 mm op-
erative laparoscope (Karl Storz®) with a 5 mm working
channel was used to perform the first four procedures
(Figure 1c). This single trocar technique was complex
because light source was insufficient and visualization of
the operating field was extremely poor. These two in-
conveniences resulted in prolonged operating times, and
three cases necessitated addition of a 5 mm trocar.
In ten cases we used a single-trocar technique with a
Multiport (Covidien SILS™ Port, Mansfield, MA, USA)
placed in the Petit’s triangle. In three patients, a 5-mm
flexible laparoscope EndoEye camera system (Olympus
Medical®, Orangeburg, NY, USA) (Figure 2) was used,
and in the remaining four subjects a bariatric 5 mm lap-
aroscope (Karl Storz®) was used with standard, reusable,
5 mm laparoscopic instruments. In two patients 5 mm
reusable and disposable bent instruments were used to
dissect the retroperitoneal space and mobilize the lateral
peritoneum from the anterior abdominal wall. In the
remaining eight patients we used standard 5 mm laparo-
scopic instruments. A working pressure of 15 mmHg
and the exposure of the lower pole of the kidney allowed
us to perform the biopsy. The biopsy was done with
5 mm biopsy forceps: three bites placed in the renal cortex.
We performed the hemostasis in the biopsy site with a
5 mm Argon beam probe and the application of oxidized
regenerated cellulose gauze. The carbon dioxide was slowly
evacuated while looking for any bleeding. Drainage was left
in place for 12–24 hours in all patients. All procedures
were performed by a single operator.
Results
All 14 LESS biopsy procedures were successfully per-
formed with sufficient tissue obtained for histopatologi-
cal diagnosis in all cases (Table 1). The operative time
ranged from 24 to 105 min (mean: 52.64 min), and the
estimated blood loss was minimum. In the first four
single-trocar cases, the procedure was complex because
the light source was insufficient and visualization of the
Table 1 Patient indications for performing LESS renal biopsy, surgical data and histopatological diagnosis based on
retroperiotneoscopic LESS renal biopsy
Age Disease Technique OT Blood loss ANP HS Histopatological diagnosis
55 Extremely obese Hybrid single trocar 85 < 50 cc No 1 day GN membranoproliferative
40 Coagulopathy Hybrid single trocar 105 < 50 cc No 1 day Membranous glomerulonephritis
66 Extremely obese Hybrid single trocar 75 < 50 cc No 1 day IgA nephropathy
62 Solitary kidney Pure single trocar 90 < 50 cc No 1 day GN membranoproliferative
58 Solitary kidney SILS Port/ Bariatric Laparoscope 38 < 50 cc No 1 day FSGS
72 Uncontrolled ipertension SILS Port/ Bariatric Laparoscope 45 < 50 cc No 1 day Membranous glomerulonephritis
79 Uncontrolled ipertension SILS Access Port/ Endo EyE 35 < 50 cc No 1 day GN membranoproliferative
77 Uncontrolled ipertension SILS Access Port/ Endo EyE 27 < 50 cc No 1 day AL amyloidosis
65 Extremely obese SILS Access Port/ Endo EyE 24 < 50 cc No 1 day FSGS
59 Solitary kidney SILS Access Port/ Endo EyE 27 < 50 cc No 1 day Membranous glomerulonephritis
80 Solitary kidney SILS Access Port/ Endo EyE 45 < 50 cc No 1 day FSGS
22 Solitary kidney SILS Access Port/ Endo EyE 39 < 50 cc No 1 day GN membranoproliferative
18 Solitary kidney SILS Access Port/ Endo EyE 42 < 50 cc No 1 day GN membranoproliferative
70 Solitary kidney SILS Access Port/ Endo EyE 60 < 50 cc No 1 day AL amyloidosis
OT: Operative time in minutes; ANP: Analgesia Post Surgery; HS Hospital Stay.
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erative times was slightly longer and ranged from 75
to 105 min (mean: 88.75 min.). All patients were dis-
charged following an overnight stay. None of the pa-
tients required narcotics or additional analgesia in the
postoperative period. No postoperative complications
occurred (Table 1).
Discussion
Histological evaluation of renal parenchyma is often ne-
cessary in cases of several renal diseases. Pathological
diagnosis often provides useful information in deter-
mining the prognosis and guiding the treatment [11].
General indications for renal biopsy include renal failure—
insufficiency of unknown etiology, nephrotic syndrome,
proteinuria, and systemic diseases with suspected renal
involvement such as systemic lupus erythematosus. Percu-
taneous renal biopsy is the most common method of
sampling renal tissue because it is performed with local
anaesthesia as outpatient surgery [12].
In addition to the risk of bleeding and fistulae during
percutaneous needle biopsy, the specimen can’t be ad-
equate to have a histopathological diagnosis. In fact, dur-
ing percutaneous procedures it is not easy obtain only
cortex sample, that is necessary to study glomerular dis-
eases. With LESS procedures, in our experience, we can
select the best site in the kidney to perform the biopsy
and we can take only cortex specimen, without medul-
lary tissue.
In our experience percutaneous renal biopsy contrain-
dications were uncontrolled hypertension, bleeding dis-
orders, extreme obesity, and a solitary kidney.With advances in endoscopic instrumentation and the
development of laparoscopic techniques, the minimally
invasive alternatives to open renal biopsy are safety and
preferable. Although surgical approaches require general
anesthesia, their advantage is that the kidney is identi-
fied, biopsied, and hemostasis is achieved under direct
vision in a controlled fashion [4]. Several papers in
the last 20 years appeared in the literature describing
the retroperitoneoscopic approach as safe and effective.
Retroperitoneal access it is technically difficult due to
the lack of landmarks, small working space, and loss of
orientation. Relative simple procedures like renal biopsy
are often performed in a retroperitoneoscopic fashion.
Data shows that this approach for renal biopsy is effect-
ive also in less experienced surgeons. With minimal
retroperitoneal dissection, the kidney is quickly identi-
fied and renal biopsy and haemostasis are safely achieved
in a reasonably short period of time [6-10].
As a result of the risks associated with additional
ports, there has been a surge of interest in a less invasive
alternative to retroperitoneoscopy. LESS has been devel-
oped in an attempt to further reduce the morbidity and
scarring associated with laparoscopic surgery [13]. Early
clinical series have demonstrated the feasibility of a
broad range of LESS urologic procedures [14]. As a gen-
eral principle, all eligible laparoscopic surgery patients
can be considered for LESS depending on the surgeon’s
experience.
In all patients the first trocar was positioned under
direct vision using the Cannule Ternamian EndoTIP
(Karl Storz®). This device allows the surgeon to open
each tissue layer under direct vision, so that the surgeon
Figure 1 Patient position and Surgical Instruments. a) Petit’s triangle. b) Ternamian EndoTIP 10 mm, Karl Storz®, Tuttlingen, Germany.
c) Operative laparoscope 10 mm, Karl Storz, Tuttlingen, Germany.
Figure 2 Our working strategy with the EndoEye Camera
(Olympus Medical, Orangeburg, NY, USA) was to place the lens
in a different plane of the instruments and compensate with
the flexible tip.
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nerves and to see the Scarpa’s fascia, the flank muscle,
and the lumbodorsal fascia. Then, after insufflation with
carbon dioxide at 15 mmHg, with this device we dissect
bluntly the retroperitoneal space and mobilize the lateral
peritoneal sheath from the anterior abdominal wall. This
device is reusable, as compared to the Visiport access
trocar (Covidien®) described in our previous experience
in pediatric patients. This reusable device allows us to
obtain results comparable to those with the Visiport ac-
cess trocar, but with a reduction of the cost surgery [8].
Our preliminary approach with LESS technique was a
single-trocar renal biopsy, performed with an operative
laparoscope (Karl Storz®) with a 5 mm working channel.
This attempt was not effective because the operative lap-
aroscope brought insufficient light into the operative
field and forced the operator to be positioned too close
to the operative field, with the kidney causing lens mist
and other residue. In these cases we performed a hybrid
LESS, without problem for the patients. In fact, there
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these four cases, except for a slightly prolonged opera-
tive time. In the remaining ten patients we used a SILS
Multiport (Covidien SILS™ Port) placed in the Petit’s tri-
angle. Today many LESS ports, disposable and reusable,
are available in the market. In this series we used the
SILS port because, in our experience, it seems to be easy to
place, standard trocars (5–10 mm) can be used, and retro-
pneumoperitoneum can be maintained without leakage.
Compared to standard laparoscopy, LESS technique
increases the difficulty of surgical procedures because of
reduced workspace, the lack of triangulation, clashing of
instruments, as has been reported in several case series
[8]. To reduce the risk of instruments clashing, we used
two laparoscopes types: in four patients a bariatric
5 mm, 0° laparoscope (Karl Stortz®) was used, and in six
patients a 5 mm flexible laparoscope EndoEye camera
system (Olympus Medical) was used. With both lens de-
vices we increase our working ability and improve our
LESS technique. Moreover, the optic with which we ob-
tained the best results was the EndoEye camera system.
This device provides more light in the operating field,
higher imaging quality, flexibility, and better working
conditions. Our working strategy with the EndoEye system
was to place the lens in a different plane of the instru-
ments and compensate with the flexible tip (Figure 2).
Various disposable instruments have been developed
to overcome the risk of clashing, minimal triangulation,
and poor range of motion. Articulating instruments
are designed to improve triangulation and external
spacing for LESS procedures [15]. In one case we used
the “Roticulator Endo Grasp” (Covidien®) forceps and
scissor. We used them to mobilize the lower pole of
the kidney, transect Gerota’s fascia, and develop a fat
window on renal parenchyma. We experienced a poor
quality of the materials with the consequent breakage
and deformation of the instrument’s tip. In one other case
we tested the pre-bent instruments (Olympus Medical).
These instruments have been introduced with the aim
of minimizing instrument clashing outside the port,
and providing triangulation in the operative field and
better force distribution during dissection with the trans-
peritoneal approach [16]. In our experience these tools
do not give better benefits because there is less working
space in the retroperitoneal space compared to the ab-
dominal cavity.
In our experience, all eligible laparoscopic surgery
patients can be considered for LESS depending on the
surgeon’s experience. According to recent updates from
the Endourological Society NOTES (Natural Orifice
Transluminal Endoscopic Surgery) and LESS Working
Group and the European Society of Urotechnology
NOTES, it has recently been stressed that LESS is appro-
priate in selected patients with limited previous abdominalsurgery [17]. Greco et al. suggest that malignant disease at
pathology and high ASA score represent predictive factors
for complications after LESS for upper urinary tract sur-
gery. Thus, surgeons approaching LESS should start with
benign diseases in low-surgical risk patients to allow an
easier surgical approach and to minimize the risk of post-
operative complications [18].
Conclusions
Retroperitoneoscopic LESS renal biopsy is a safe and
feasible procedure. With consolidated laparoscopic ex-
perience with retroperitoneal access, LESS renal biopsy
is a good choice of procedure. Moreover, all our subjects
underwent same-day procedures, no pain medication were
used after surgery, and subjects experienced excellent cos-
metic results. Our next step will be a randomized prospect-
ive study of LESS compared with laparoscopy for renal
biopsy.
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